About Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
AUPH - Aurinia Pharmaceutic...| Previous Close | $14.38 | Open | |
| Volume | 148.1K | Market Cap | 1.836B |
| Yield | Last Dividend |
| Aurinia Pharmaceuticals to Release Fourt... | 02/17/21 |
| VICTORIA, British Columbia--(BUSINESS WIRE)--Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) (the ???Company???) today announced that it will r... | |
| Insider Buying: Aurinia Pharmaceuticals ... | 02/04/21 |
| Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) (TSE:AUP) Director Jill Leversage bought 1,200 shares of the company???s stock in a transaction on Friday, ... | |
| Shark Bites: Anatomy of a Trade - Aurini... | 02/01/21 |
| Anatomy of a Trade - Aurinia Pharmaceuticals (AUPH)???AUPH | |
| Attention Biotech Investors: Mark Your C... | 01/31/21 |
| Coming off a stellar year, when a record 53 new molecular entities were approved, 2021 has a lot to live up to. NMEs are a measure of innovation among... | |
| Why Aurinia Pharma, AstraZeneca And More... | 01/25/21 |
| AstraZeneca (NASDAQ: AZN) shares are trading higher Monday after the company's CALQUENCE met its primary efficacy endpoint. The German Health Minister... | |
| STAT+: Aurinia secures FDA drug approval... | 01/24/21 |
| Aurinia Pharmaceuticals won approval to market a new medicine for patients with lupus nephritis, a serious autoimmune kidney disease. | |
| The Week Ahead In Biotech (Jan 24-30): J... | 01/23/21 |
| Biopharma stocks advanced yet again in the week ended Jan. 22, with the change of guard at the White House generating broader market strength. Eli Lil... | |
| FDA Approves Aurinia Pharma's Lupkynis -... | 01/22/21 |
| The FDA has approved Aurinia Pharmaceuticals Inc.'s (AUPH) LUPKYNIS in combination with a background immunosuppressive therapy regimen to treat adult ... | |
| Lupus Foundation of America Congratulate... | 01/22/21 |
| WASHINGTON, Jan. 22, 2021 /PRNewswire/ ??? For the second time in less than two months, the U.S. Food and Drug Administration (FDA) has approved a new... | |
| FDA Approves Aurinia Pharmaceuticals??? ... | 01/22/21 |
| Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) (???Aurinia??? or the ???Company???) today announced that the U.S. Food and Drug Administration... | |
| Victoria???s Aurinia Pharmaceuticals day... | 01/17/21 |
| Until recently there was no FDA-approved drug to treat Lupus, a chronic disease that prompts the immune system to attack the body???s organs | |
| STAT+: Aurinia in ???show-me phase??? as... | 01/15/21 |
| Aurinia Pharmaceuticals is in a "show-me phase" as the FDA nears an approval decision on its drug for lupus nephritis, a serious autoimmune kidney dis... | |
| Aurinia Pharmaceuticals to Present at Tw... | 01/08/21 |
| VICTORIA, British Columbia--(BUSINESS WIRE)--Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) (the ???Company???) today announced that members o... | |
| My Top Six 2020 Stock Picks Gained an Av... | 12/30/20 |
| A few of these names continue to look good in 2021???.AUPH | |
| H.C. Wainwright Stick to Their Buy Ratin... | 12/16/20 |
| H.C. Wainwright Stick to Their Buy Rating for Aurinia Pharmaceuticals | |
| Aurinia and Lonza Announce Exclusive Agr... | 12/15/20 |
| VICTORIA, British Columbia--(BUSINESS WIRE)--Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) (???Aurinia???) and Lonza Ltd. (SIX: LONN) ("Lonza... | |
| Aurinia Pharmaceuticals to Present at th... | 12/02/20 |
| VICTORIA, British Columbia--(BUSINESS WIRE)--Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) (the ???Company???) today announced its participat... | |
| Aurinia Pharmaceuticals to Present at th... | 11/12/20 |
| VICTORIA, British Columbia--(BUSINESS WIRE)--Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) (the ???Company???) today announced that members o... | |
| Why Aurinia Pharmaceuticals Stock Is Tra... | 11/03/20 |
| Share this Stock Information Aurinia Pharmaceuticals (NASDAQ: AUPH) shares are trading lower on Tuesday after the company reported its AUDREY trial in... | |
| Aurinia Pharma???s Dry Eye Study Blanks ... | 11/03/20 |
| No summary available. | |
| The Daily Biotech Pulse: Aurinia Pulls T... | 11/03/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Nov. 2) Bio-... | |
| Aurinia Tanks 10% As Dry Eye Trial Fails... | 11/03/20 |
| Shares in Aurinia Pharmaceuticals (AUPH) tanked 10% after-hours after the biopharma announced disappointing topline data from the Phase 2/3 Audrey cli... | |
| Aurinia Announces Outcome of AUDREY??? C... | 11/02/20 |
| Aurinia Pharmaceuticals Inc. (Nasdaq: AUPH / TSX:AUP) (???Aurinia??? or the ???Company???), a late-stage clinical biopharmaceutical company, today ann... | |
| Aurinia Announces European Investigator-... | 10/27/20 |
| VICTORIA, British Columbia--(BUSINESS WIRE)--Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) (TSX:AUP) (???Aurinia??? or the ???Company???), a late-stage c... | |
| Aurinia Presents Voclosporin Efficacy an... | 10/22/20 |
| VICTORIA, British Columbia--(BUSINESS WIRE)--Aurinia Pharmaceuticals Inc. (Nasdaq:AUPH / TSX:AUP) (???Aurinia??? or the ???Company???), a late-stage c... | |
| Analysts Anticipate Aurinia Pharmaceutic... | 10/20/20 |
| Equities research analysts expect that Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) (TSE:AUP) will post earnings per share of ($0.22) for the current qua... | |
| Shark Bites: Positioning for a Positive ... | 10/05/20 |
| AUPH has two very large market opportunities for its voclosporin drug???.AUPH | |
| Aurinia Completes Final Patient Treatmen... | 09/28/20 |
| VICTORIA, British Columbia--(BUSINESS WIRE)--Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX:AUP) (Aurinia or the Company), a late-stage clinical bio... | |
| Aurinia Announces New Employment Inducem... | 09/04/20 |
| VICTORIA, British Columbia & ROCKVILLE, Md.--(BUSINESS WIRE)--Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) (TSX:AUP) (???Aurinia??? or the ???Company???... | |
| Recap: Aurinia Pharmaceuticals Q2 Earnin... | 08/11/20 |
| Shares of Aurinia Pharmaceuticals (NASDAQ:AUPH) were unchanged after-market trading after the company reported Q2 results. Quarterly Results Earnings ... | |
| Strong Buy rating | 01/27/21 |
| SVB Leerink maintains Outperform rating and raises Price Target from $24.00 to $28.00 | |
| Buy rating | 01/25/21 |
| HC Wainwright & Co. maintains Buy rating and raises Price Target from $30.00 to $35.00 | |
| Date | 2021-02-24 (AMC) | Est. (EPS/Rev.) | ($0.14)/ 40K |
| Actual (EPS/Rev.) | $-0.05/ $50.03 M | EPS (TTM) | 0 |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| Trading Systems | Trading Systems | 83.00 % | Subscribe |
| The Winning Trader | Stock Trader D | 60.00 % | Subscribe |
| Symmetry Options | Symmetry Options | 33.00 % | Follow |
| Biotechnology | Robert Gadimian | 26.00 % | Follow |
| cerevisiology | John Cho | 19.00 % | Follow |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
